BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Diagnosis
4 results:

  • 1. Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach.
    Tuncel M; Lay Ergun E; Caglar Tuncali M
    J BUON; 2016; 21(5):1296-1306. PubMed ID: 27837636
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.
    Hernandez DJ; Han M; Humphreys EB; Mangold LA; Taneja SS; Childs SJ; Bartsch G; Partin AW
    BJU Int; 2009 Mar; 103(5):609-14. PubMed ID: 19007374
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Characterisation of families with hereditary prostate cancer in the Netherlands].
    Meulenbeld HJ; Verhage BA; Kil PJ; Kiemeney LA; Vasen HF
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1938-42. PubMed ID: 12404910
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prostatic aspiration cytology.
    Lin BP; Davies WE; Harmata PA
    Pathology; 1979 Oct; 11(4):607-14. PubMed ID: 530750
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.